Hospitals start pilot testing RFID to curb drug diversion

Article

M.D. Anderson Cancer Center in Houston is testing RFID on two medications, Neupogen (filgrastim, Amgen) and Procrit (epoetin alfa, Ortho Biotech).

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Image Credit: jokekung - stock.adobe.com
Image Credit: gamelover - stock.adobe.com
Image Credit: anidimi - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.